US FDA Declines to Approve Atara’s Therapy for Rare Blood Cancer

by | Jan 12, 2026 | Health

Spread the love
The U.S. Food and Drug Administration on Monday declined to approve Atara Biotherapeutics’ cell therapy for ‌a rare form of blood cancer, the company said, sending its…
Reuters Health Information

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments